BNP Paribas Financial Markets
ECTE

BNP Paribas Financial Markets’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

BNP Paribas Financial Markets’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-147
Closed -$332 – 4423
2014
Q2 		$332 Hold
147
– – ﹤0.01% 3650
2014
Q1 		$457 Hold
147
– – ﹤0.01% 3062
2013
Q4 		$462 Buy
+147
New +$410 ﹤0.01% 3947

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BNP Paribas Financial Markets's ECTE Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2014, closing a stake of 147 shares — an estimated $332 sold.

BNP Paribas Financial Markets first reported a position in ECTE in Q4 2013 and held it in 3 quarters. The position peaked at $462 in Q4 2013. 26 funds tracked by Wall St. Rank hold ECTE as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 147 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2014, an estimated $332.
  • BNP Paribas Financial Markets first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $462 in Q4 2013.
  • 26 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.